| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Boston Scientific Corporation (NYSE: BSX)
BSX Technical Analysis
3
| As on 25th Nov 2025 BSX SHARE Price closed @ 101.36 and we RECOMMEND Buy for LONG-TERM with Stoploss of 100.39 & Buy for SHORT-TERM with Stoploss of 96.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BSXSHARE Price
| Open | 98.85 | Change | Price | % |
| High | 101.77 | 1 Day | 3.32 | 3.39 |
| Low | 98.74 | 1 Week | -1.33 | -1.30 |
| Close | 101.36 | 1 Month | 5.12 | 5.32 |
| Volume | 8822565 | 1 Year | 10.70 | 11.80 |
| 52 Week High 108.14 | 52 Week Low 88.03 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| TWTR | 53.70 | 0.66% |
| SWN | 7.11 | -0.56% |
| BACA-U | 302.00 | 0.67% |
| ENLC | 14.12 | -0.21% |
| NIO | 5.50 | -4.35% |
| RPAI | 13.15 | -3.17% |
| LTHM | 16.51 | -8.53% |
| JWN | 24.66 | 0.08% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| BSX Daily Charts |
BSX Intraday Charts |
Whats New @ Bazaartrend |
BSX Free Analysis |
|
|
BSX Important Levels Intraday
| RESISTANCE | 107.20 |
| RESISTANCE | 105.33 |
| RESISTANCE | 104.17 |
| RESISTANCE | 103.01 |
| SUPPORT | 99.71 |
| SUPPORT | 98.55 |
| SUPPORT | 97.39 |
| SUPPORT | 95.52 |
BSX Forecast November 2025
| 4th UP Forecast | 133.44 |
| 3rd UP Forecast | 123.15 |
| 2nd UP Forecast | 116.79 |
| 1st UP Forecast | 110.43 |
| 1st DOWN Forecast | 92.29 |
| 2nd DOWN Forecast | 85.93 |
| 3rd DOWN Forecast | 79.57 |
| 4th DOWN Forecast | 69.28 |
BSX Weekly Forecast
| 4th UP Forecast | 106.87 |
| 3rd UP Forecast | 105.10 |
| 2nd UP Forecast | 104.01 |
| 1st UP Forecast | 102.92 |
| 1st DOWN Forecast | 99.80 |
| 2nd DOWN Forecast | 98.71 |
| 3rd DOWN Forecast | 97.62 |
| 4th DOWN Forecast | 95.85 |
BSX Forecast2025
| 4th UP Forecast | 146.68 |
| 3rd UP Forecast | 132.15 |
| 2nd UP Forecast | 123.16 |
| 1st UP Forecast | 114.18 |
| 1st DOWN Forecast | 88.54 |
| 2nd DOWN Forecast | 79.56 |
| 3rd DOWN Forecast | 70.57 |
| 4th DOWN Forecast | 56.04 |
Boston Scientific Corporation ( NYSE USA Symbol : BSX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BSX Business Profile
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. Address: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service